In the race to advance medical innovation to improve lives, there’s no room for error and no time to wait. Yet on the path to demonstrating clinical value, lack of resources, unclear testing strategies and laboratory quality/regulatory audit issues can stall out design and development timelines. Companies developing medical solutions need a clear, direct path to advance innovations to the clinical study phase. With a stellar compliance record and more than four decades of clinical expertise in bringing breakthrough technologies to market, Synchrony Labs partners with leading medical device and biotech companies to create and execute preclinical strategies. We are a premiere full service contract research organization specializing in preclinical models for safety, toxicology, and efficacy studies for pharmaceutical, biotechnology, and medical device companies. Our laboratory originated at Duke Medical Center and has conducted studies for major medical device companies. Synchrony Labs was formed as an independent contract research facility in 2001.